Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Adjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data.

Opfermann KJ, Wahlquist AE, Garrett-Mayer E, Shridhar R, Cannick L, Marshall DT.

Am J Clin Oncol. 2014 Apr;37(2):112-6. doi: 10.1097/COC.0b013e31826e0570.

2.

The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704.

Showalter TN, Winter KA, Berger AC, Regine WF, Abrams RA, Safran H, Hoffman JP, Benson AB, MacDonald JS, Willett CG.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1328-35. doi: 10.1016/j.ijrobp.2010.07.1993. Epub 2010 Oct 8.

3.

Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry.

Worni M, Akushevich I, Gloor B, Scarborough J, Chino JP, Jacobs DO, Hahn SM, Clary BM, Pietrobon R, Shah A.

Ann Surg Oncol. 2012 Apr;19(4):1316-23. doi: 10.1245/s10434-011-2088-2. Epub 2011 Oct 15.

PMID:
22002799
4.

Revisiting the concept of lymph node metastases of pancreatic head cancer: number of metastatic lymph nodes and lymph node ratio according to N stage.

Kang MJ, Jang JY, Chang YR, Kwon W, Jung W, Kim SW.

Ann Surg Oncol. 2014 May;21(5):1545-51. doi: 10.1245/s10434-013-3473-9. Epub 2014 Jan 14.

PMID:
24419758
5.

Lymph node ratio is an independent prognostic factor after resection of periampullary malignancies: data from a tertiary referral center in the middle East.

Shamseddine AI, Mukherji D, Melki C, Elias E, Eloubeidi M, Dimassi H, Khalife M, Abou-Alfa G, O'Reilly E, Faraj W.

Am J Clin Oncol. 2014 Feb;37(1):13-8. doi: 10.1097/COC.0b013e31826b9c74.

PMID:
23111358
6.

Adjuvant radiotherapy and lymph node dissection in pancreatic cancer treated with surgery and chemotherapy.

Mellon EA, Springett GM, Hoffe SE, Hodul P, Malafa MP, Meredith KL, Fulp WJ, Zhao X, Shridhar R.

Cancer. 2014 Apr 15;120(8):1171-7. doi: 10.1002/cncr.28543. Epub 2014 Jan 3.

7.

The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.

Berger AC, Watson JC, Ross EA, Hoffman JP.

Am Surg. 2004 Mar;70(3):235-40; discussion 240.

PMID:
15055847
8.

Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.

Slidell MB, Chang DC, Cameron JL, Wolfgang C, Herman JM, Schulick RD, Choti MA, Pawlik TM.

Ann Surg Oncol. 2008 Jan;15(1):165-74. Epub 2007 Sep 26.

PMID:
17896141
9.

Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio.

Renaud S, Falcoz PE, Olland A, Reeb J, Santelmo N, Massard G.

Interact Cardiovasc Thorac Surg. 2015 Feb;20(2):222-7. doi: 10.1093/icvts/ivu378. Epub 2014 Nov 20.

PMID:
25413781
10.

Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival.

Morales-Oyarvide V, Rubinson DA, Dunne RF, Kozak MM, Bui JL, Yuan C, Qian ZR, Babic A, Da Silva A, Nowak JA, Khalaf N, Brais LK, Welch MW, Zellers CL, Ng K, Chang DT, Miksad RA, Bullock AJ, Tseng JF, Swanson RS, Clancy TE, Linehan DC, Findeis-Hosey JJ, Doyle LA, Hornick JL, Ogino S, Fuchs CS, Hezel AF, Koong AC, Wolpin BM.

Br J Cancer. 2017 Dec 5;117(12):1874-1882. doi: 10.1038/bjc.2017.349. Epub 2017 Oct 5.

PMID:
28982112
11.

Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer.

Jonnalagadda S, Arcinega J, Smith C, Wisnivesky JP.

Cancer. 2011 Oct 15;117(20):4724-31. doi: 10.1002/cncr.26093. Epub 2011 Mar 30.

12.

Nodal counts and lymph node ratio impact survival after distal pancreatectomy for pancreatic adenocarcinoma.

Ashfaq A, Pockaj BA, Gray RJ, Halfdanarson TR, Wasif N.

J Gastrointest Surg. 2014 Nov;18(11):1929-35. doi: 10.1007/s11605-014-2566-5. Epub 2014 Jun 11.

PMID:
24916590
13.

Prognostic value of the lymph node ratio after resection of periampullary carcinomas.

Farid SG, Falk GA, Joyce D, Chalikonda S, Walsh RM, Smith AM, Morris-Stiff G.

HPB (Oxford). 2014 Jun;16(6):582-91. doi: 10.1111/j.1477-2574.2012.00614.x. Epub 2012 Nov 19.

14.

Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas.

Conrad C, Kutlu OC, Dasari A, Chan JA, Vauthey JN, Adams DB, Kim M, Fleming JB, Katz MH, Lee JE.

J Gastrointest Surg. 2016 Dec;20(12):1966-1974. Epub 2016 Oct 6.

PMID:
27714644
15.

Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer.

Coburn NG, Swallow CJ, Kiss A, Law C.

Cancer. 2006 Nov 1;107(9):2143-51.

16.

Lymph node ratio may predict the benefit of postoperative radiotherapy in node-positive cervical cancer.

Zhou J, Chen QH, Wu SG, He ZY, Sun JY, Li FY, Lin HX, You KL.

Oncotarget. 2016 May 17;7(20):29420-8. doi: 10.18632/oncotarget.8840.

17.

Lymph node status predicts the benefit of adjuvant chemoradiotherapy for patients with resected pancreatic cancer.

Liu Z, Luo G, Guo M, Jin K, Xiao Z, Liu L, Liu C, Xu J, Ni Q, Long J, Yu X.

Pancreatology. 2015 May-Jun;15(3):253-8. doi: 10.1016/j.pan.2015.03.012. Epub 2015 Apr 2.

PMID:
25921232
18.

Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?

Hakeem AR, Marangoni G, Chapman SJ, Young RS, Nair A, Hidalgo EL, Toogood GJ, Wyatt JI, Lodge PA, Prasad KR.

Eur J Gastroenterol Hepatol. 2014 Sep;26(9):1047-54. doi: 10.1097/MEG.0000000000000162.

PMID:
25051217
19.

Surgical Management of Intrahepatic Cholangiocarcinoma: Defining an Optimal Prognostic Lymph Node Stratification Schema.

Kim Y, Spolverato G, Amini N, Margonis GA, Gupta R, Ejaz A, Pawlik TM.

Ann Surg Oncol. 2015 Aug;22(8):2772-8. doi: 10.1245/s10434-015-4419-1. Epub 2015 Feb 7.

PMID:
25663595
20.

Radical prostatectomy for clinical T4 prostate cancer.

Johnstone PA, Ward KC, Goodman M, Assikis V, Petros JA.

Cancer. 2006 Jun 15;106(12):2603-9.

Supplemental Content

Support Center